Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 214382
Company: SHANDONG

Products on ANDA 214382

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
SEVOFLURANE	SEVOFLURANE	100%	LIQUID;INHALATION	Prescription	AN	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 214382

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
08/18/2023	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 214382

SEVOFLURANE

LIQUID;INHALATION; 100%
TE Code = AN

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
SEVOFLURANE	SEVOFLURANE	100%	LIQUID;INHALATION	Prescription	No	AN	075895	BAXTER HLTHCARE
SEVOFLURANE	SEVOFLURANE	100%	LIQUID;INHALATION	Prescription	No	AN	078650	HALOCARBON PRODS
SEVOFLURANE	SEVOFLURANE	100%	LIQUID;INHALATION	Prescription	No	AN	214382	SHANDONG
SEVOFLURANE	SEVOFLURANE	100%	LIQUID;INHALATION	Prescription	No	AN	203793	SHANGHAI HENGRUI
SOJOURN	SEVOFLURANE	100%	LIQUID;INHALATION	Prescription	No	AN	077867	PIRAMAL CRITICAL
ULTANE	SEVOFLURANE	100%	LIQUID;INHALATION	Prescription	Yes	AN	020478	ABBVIE